FR2267773B1 - - Google Patents

Info

Publication number
FR2267773B1
FR2267773B1 FR7511796A FR7511796A FR2267773B1 FR 2267773 B1 FR2267773 B1 FR 2267773B1 FR 7511796 A FR7511796 A FR 7511796A FR 7511796 A FR7511796 A FR 7511796A FR 2267773 B1 FR2267773 B1 FR 2267773B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7511796A
Other languages
French (fr)
Other versions
FR2267773A1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EIDP Inc
Original Assignee
EI Du Pont de Nemours and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EI Du Pont de Nemours and Co filed Critical EI Du Pont de Nemours and Co
Publication of FR2267773A1 publication Critical patent/FR2267773A1/fr
Application granted granted Critical
Publication of FR2267773B1 publication Critical patent/FR2267773B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/46—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom
    • C07D333/48—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D331/00—Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom
    • C07D331/04—Four-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR7511796A 1974-04-17 1975-04-16 Expired FR2267773B1 (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46169974A 1974-04-17 1974-04-17
US05/555,307 US4009847A (en) 1974-04-17 1975-03-11 1-Tertiary-alkyl-3-(substituted thienyl)ureas and 1-tertiary-alkyl-3-(substituted thietyl)ureas as antihypertensive agents

Publications (2)

Publication Number Publication Date
FR2267773A1 FR2267773A1 (enExample) 1975-11-14
FR2267773B1 true FR2267773B1 (enExample) 1978-08-18

Family

ID=27040095

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7511796A Expired FR2267773B1 (enExample) 1974-04-17 1975-04-16

Country Status (21)

Country Link
US (1) US4009847A (enExample)
JP (1) JPS50148349A (enExample)
AR (1) AR208545A1 (enExample)
CA (1) CA1047042A (enExample)
CH (1) CH611292A5 (enExample)
DD (1) DD117223A5 (enExample)
DE (1) DE2516554A1 (enExample)
DK (1) DK164175A (enExample)
ES (1) ES436648A1 (enExample)
FI (1) FI751128A7 (enExample)
FR (1) FR2267773B1 (enExample)
GB (1) GB1461209A (enExample)
HU (1) HU173052B (enExample)
IE (1) IE41143B1 (enExample)
IL (1) IL47095A (enExample)
LU (1) LU72306A1 (enExample)
NL (1) NL7504570A (enExample)
NO (1) NO144071C (enExample)
PH (1) PH11722A (enExample)
SE (1) SE417965B (enExample)
YU (1) YU96075A (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4156738A (en) * 1977-10-07 1979-05-29 E. I. Du Pont De Nemours And Company Ureidonitriles useful as antihypertensives
US6187799B1 (en) * 1997-05-23 2001-02-13 Onyx Pharmaceuticals Inhibition of raf kinase activity using aryl ureas
US6344476B1 (en) 1997-05-23 2002-02-05 Bayer Corporation Inhibition of p38 kinase activity by aryl ureas
US7517880B2 (en) 1997-12-22 2009-04-14 Bayer Pharmaceuticals Corporation Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
US7329670B1 (en) 1997-12-22 2008-02-12 Bayer Pharmaceuticals Corporation Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
US20080300281A1 (en) * 1997-12-22 2008-12-04 Jacques Dumas Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas
US20080269265A1 (en) * 1998-12-22 2008-10-30 Scott Miller Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
ME00275B (me) * 1999-01-13 2011-02-10 Bayer Corp ω-KARBOKSIARIL SUPSTITUISANI DIFENIL KARBAMIDI KAO INHIBITORI RAF KINAZE
US8124630B2 (en) * 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
EP1140840B1 (en) 1999-01-13 2006-03-22 Bayer Pharmaceuticals Corp. -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
EP2298311B1 (en) * 1999-01-13 2012-05-09 Bayer HealthCare LLC w-Carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
US7928239B2 (en) 1999-01-13 2011-04-19 Bayer Healthcare Llc Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
US7235576B1 (en) 2001-01-12 2007-06-26 Bayer Pharmaceuticals Corporation Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7371763B2 (en) * 2001-04-20 2008-05-13 Bayer Pharmaceuticals Corporation Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
MXPA04005137A (es) * 2001-12-03 2005-06-03 Bayer Pharmaceuticals Corp Compuestos de aril urea en combinacion con otros agentes citostaticos para el tratamiento de canceres humanos.
US20080108672A1 (en) * 2002-01-11 2008-05-08 Bernd Riedl Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors
ES2425739T3 (es) * 2002-02-11 2013-10-17 Bayer Healthcare Llc Sorafenib-tosilato para el tratamiento de enfermedades caracterizadas por angiogénesis anormal
DK1580188T3 (da) 2002-02-11 2012-02-06 Bayer Healthcare Llc Forbindelser af arylurea som kinaseinhibitorer
AU2003209119A1 (en) * 2002-02-11 2003-09-04 Bayer Pharmaceuticals Corporation Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
AU2003210969A1 (en) * 2002-02-11 2003-09-04 Bayer Corporation Aryl ureas with raf kinase and angiogenesis inhibiting activity
US7557129B2 (en) * 2003-02-28 2009-07-07 Bayer Healthcare Llc Cyanopyridine derivatives useful in the treatment of cancer and other disorders
CA2526636C (en) * 2003-05-20 2012-10-02 Bayer Pharmaceuticals Corporation Diaryl ureas for diseases mediated by pdgfr
BR122016015715B8 (pt) * 2003-07-23 2021-05-25 Bayer Healthcare Llc composições farmacêuticas de metilamida de ácido 4[4-[3-(4-cloro-3-trifluorometilfenil)-ureido]-3-fluorofenóxi)-piridina-2-carboxílico
EP2295427A1 (en) * 2004-04-30 2011-03-16 Bayer HealthCare, LLC Substituted pyrazolyl urea derivatives useful in the treatment of cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH452475A (de) * 1965-05-20 1968-05-31 Bayer Ag Verfahren zum Färben und Bedrucken von synthetischem Textilmaterial mit Anthrachinonfarbstoffen

Also Published As

Publication number Publication date
IE41143L (en) 1975-10-17
NO144071C (no) 1981-06-17
AR208545A1 (es) 1977-02-15
IL47095A0 (en) 1975-06-25
GB1461209A (en) 1977-01-13
FR2267773A1 (enExample) 1975-11-14
HU173052B (hu) 1979-02-28
IL47095A (en) 1978-03-10
AU8013575A (en) 1976-10-21
DE2516554A1 (de) 1975-10-30
LU72306A1 (enExample) 1976-03-17
NO751351L (enExample) 1975-10-20
IE41143B1 (en) 1979-10-24
ES436648A1 (es) 1977-08-01
DK164175A (da) 1975-10-18
DD117223A5 (enExample) 1976-01-05
NO144071B (no) 1981-03-09
PH11722A (en) 1978-05-30
SE417965B (sv) 1981-04-27
US4009847A (en) 1977-03-01
FI751128A7 (enExample) 1975-10-18
NL7504570A (nl) 1975-10-21
CA1047042A (en) 1979-01-23
YU96075A (en) 1983-04-27
CH611292A5 (enExample) 1979-05-31
JPS50148349A (enExample) 1975-11-27
SE7503523L (sv) 1975-10-20

Similar Documents

Publication Publication Date Title
FI753031A7 (enExample)
FR2267773B1 (enExample)
DK140092C (enExample)
FR2257946B1 (enExample)
FI752123A7 (enExample)
FI753055A7 (enExample)
FI750994A7 (enExample)
AU7462274A (enExample)
AR198563A1 (enExample)
CS164320B1 (enExample)
AR198999Q (enExample)
FI752530A7 (enExample)
AU1893276A (enExample)
AU479725A (enExample)
AU481479A (enExample)
AU480465A (enExample)
AU480308A (enExample)
AU480049A (enExample)
AU479769A (enExample)
AU479768A (enExample)
AU479448A (enExample)
AU480660A (enExample)
AU480863A (enExample)
AU481291A (enExample)
AU481423A (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse